> Physiology > Clinical Attribute > Venous Pressure, Central

Venous Pressure, Central

Venous Pressure, Central refers to the pressure within the major veins that carry blood from the upper and lower body back to the heart.
This pressure is an important indicator of cardiovascular function and is influenced by factors such as blood volume, venous tone, and the activity of the heart.
Monitoring central venous pressure can provide valuable insights into a patient's hemodynamic status and guide clinical decision-making.
Researchers and clinicians can leverage PubCompare.ai's AI-driven platform to easily locate and compare research protocols related to central venous pressure, identifying the best approach for their needs and accelerating their work.

Most cited protocols related to «Venous Pressure, Central»

Cerebral Autoregulation Monitoring During Surgery

Patients were attached to either an INVOS (Somenetics, Inc., Troy, MI) or Foresight (CAS Medical Systems, Branford, CT) NIRS monitor, depending on availability. Electrodes for monitoring NIRS were placed on the right and left forehead using the respective manufacturer’s recommendations and after first cleaning the skin with an alcohol swab. Transcranial Doppler monitoring (Doppler Box, DWL, Compumedics, USA, Charlotte, NC) of the middle cerebral arteries was with two 2.5-MHz transducers fitted on a headband. The depth of insonation varied between 35 and 52 mm until representative spectral artery flow was identified.
Analog arterial pressure data from the operating room hemodynamic monitor, TCD, and NIRS signals were sampled with an analog-to-digital converter at 60 Hz and then processed with ICM+ software version 6.1 (University of Cambridge, Cambridge, UK). These signals were time-integrated as non-overlapping 10-second mean values, which is equivalent to applying a moving average filter with a 10-second time window and re-sampling at 0.1 Hz. This operation was used to eliminate high-frequency noise from the respiratory and pulse frequencies, while allowing detection of oscillations and transients that occur below 0.05 Hz. Doppler, oximetry, and arterial blood pressure waveforms were further high pass filtered with a DC cutoff set at 0.003 Hz. This step removed slow drifts associated with hemodilution at the onset of bypass, blood transfusions, cooling, and rewarming. A continuous, moving Pearson’s correlation coefficient was calculated between the MAP and TCD blood flow velocities and between MAP and NIRS data, rendering the variables Mx (mean velocity index) and COx (cerebral oximetry index), respectively. Of note, MAP is used in this calculation and not cerebral perfusion pressure since intracranial pressure data are not available and since central venous pressure is often negative as a result of suction assisted venous drainage to the CPB reservoir. Consecutive, paired, 10-second averaged values from 300 seconds duration were used for each calculation, incorporating 30 data points for each index. Intact CBF autoregulation is indicated by an Mx value of approximately zero (CBF and MAP are not correlated), and CBF dysautoregulation is indicated by an Mx value approaching +1 (CBF and MAP correlated). Similar findings occur experimentally with COx.^{13 (link)}

Brady K., Joshi B., Zweifel C., Smielewski P., Czosnyka M., Easley R.B, & Hogue CW J.r. (2010). Real Time Continuous Monitoring of Cerebral Blood Flow Autoregulation using Near-Infrared Spectroscopy in Patients Undergoing Cardiopulmonary Bypass. Stroke, 41(9), 1951-1956.

Publication 2010

Arteries Blood Flow Velocity Blood Transfusion Drainage Ethanol Forehead Hemodilution Hemodynamic Monitoring High-Frequency Ventilation Homeostasis Indwelling Catheter Intracranial Pressure Middle Cerebral Artery Oximetry Patients Pulse Rate Skin Spectroscopy, Near-Infrared Suction Drainage Transducers Transients Venous Pressure, Central

Early Goal-Directed Therapy for Sepsis Management

Cardiovascular support was guided by our institutional protocol for EGDT.[15 (link)] Early goal-directed therapy is a resuscitation protocol for patients with evidence of acute sepsis-induced tissue hypoperfusion, and it is recommended by international consensus guidelines for sepsis management.[16 (link), 17 (link)] Our institution has been using EGDT in routine practice since 2004, and subjects in this study were treated with EGDT as part of standard care.[15 (link)] Briefly, our EGDT protocol (an adaptation of the original protocol from Rivers et al[18 (link)]) uses intravenous volume expansion and (if needed) vasopressors, inotropes, or blood products in a stepwise manner to achieve pre-defined quantitative endpoints of resuscitation derived from invasive hemodynamic monitoring: central venous pressure (CVP) ≥8 mmHg, mean arterial pressure (MAP) ≥65 mmHg, and central venous oxygen saturation (ScvO₂) ≥70%. Our EGDT protocol can be utilized for sepsis patients in the ED; alternatively, for inpatients that develop severe sepsis in the hospital, our protocol can be initiated upon arrival to the ICU, where a pulmonary artery catheter can be used in place of a central venous catheter. If a pulmonary artery catheter is used, mixed venous oxygen saturation (SvO₂) ≥65% replaces the ScvO₂ target.[13 (link)]

Trzeciak S., McCoy J.V., Dellinger R.P., Arnold R.C., Rizzuto M., Abate N.L., Shapiro N.I., Parrillo J.E, & Hollenberg S.M. (2008). Early Increases in Microcirculatory Perfusion During Protocol-Directed Resuscitation are Associated with Reduced Multi-Organ Failure at 24 hours in Patients with Sepsis. Intensive care medicine, 34(12), 2210-2217.

Publication 2008

Acclimatization BLOOD Cardiovascular System Catheters Early Goal-Directed Therapy Inotropism Inpatient Oxygen Saturation Patients Pulmonary Artery Resuscitation Rivers Septicemia Severe Sepsis Tissues Vasoconstrictor Agents Veins Venous Catheter, Central Venous Pressure, Central

Hemodynamic Measurements in Spontaneously Breathing Rats

For hemodynamic measurements the “closed chest” method in spontaneously breathing rats was used as described earlier [10] (link). All measurements were performed under tiletamine/zolazepam anesthesia (Zoletil®, 10 mg/kg s.c. followed by 50 mg/kg i.m.) 28±2 days after fistula induction [11] . The rats were placed on a heating pad to maintain body temperature. After tracheotomy a PE-50 tubing catheter was inserted via the left jugular vein into the superior vena cava for assessment of central venous pressure. Arterial blood pressure was measured by cannulating the right carotid artery with a micro-tip pressure-volume conductance catheter (Millar®, SPR-838 NR). By further advancing the catheter into the left ventricle intraventricular pressures and volumes were registered. The position of the catheter was optimized aiming for maximal stroke volume (SV). For measurement of the parallel conductance volume 100 µl of 15% saline were injected into the central venous line to determine the correction factor for the blood-LV tissue interface, however, inhomogeneity of the electric field was not corrected. Heart rate was derived from the ECG signal. After completion of cannulation there was a 10–15 minute equilibration period before starting the measurements. All measurements were performed in spontaneously breathing rats without mechanical ventilation. All signals were recorded and analyzed by the PowerLab®-system and software (ADInstruments, Dunedin, New Zealand). After completion of the hemodynamic measurements animals were killed by exsanguination and organs were eviscerated for further determinations.

Treskatsch S., Feldheiser A., Rosin A.T., Sifringer M., Habazettl H., Mousa S.A., Shakibaei M., Schäfer M, & Spies C.D. (2014). A Modified Approach to Induce Predictable Congestive Heart Failure by Volume Overload in Rats. PLoS ONE, 9(1), e87531.

Publication 2014

Anesthesia Animals Body Temperature Cannulation Catheters Chest Common Carotid Artery Electricity Exsanguination Fistula Hemodynamics Jugular Vein Left Ventricles Mechanical Ventilation Pressure Rate, Heart Rattus Saline Solution Stroke Volume Thromboplastin tiletamine - zolazepam Tracheostomy Veins Vena Cavas, Superior Venous Catheter, Central Venous Pressure, Central Zoletil

Gastrointestinal Failure in Mechanically Ventilated Patients

All mechanically ventilated patients subsequently admitted to the mixed surgical-medical ICU of Tartu University Hospital from September 2006 to September 2007 were screened for inclusion in the present prospective study. Patients treated for at least 24 hours were included in further analyses. On admission, the following parameters were recorded: age, sex, body mass index, readmission rate, diabetes, Acute Physiology and Chronic Health Evaluation (APACHE II) score [15 (link)], surgical profile, and whether laparatomy was performed (immediately before ICU admission or during the first 24 hours). The SOFA score [16 (link)], mean arterial pressure, central venous pressure, peak inspiratory pressure, positive end-expiratory pressure, IAP, lactate, fluid gain, use of vasopressor/inotrope and sedation were recorded on daily basis. Gastrointestinal function of the patients was assessed daily using the GIF score, described in Table 1.
Enteral feeding was started as early as possible, but not within the first days after major abdominal surgery. Food intolerance (FI) was diagnosed when applied enteral feeding appeared to be unsuccessful and had to be discontinued because of repeated or profuse vomiting, high gastric residuals, ileus, severe diarrhoea, abdominal pain, or distension. FI was not registered when the patient was electively not fed during the first 3 days after laparatomy. Gastric residual volume was considered to be high when it exceeded the volume previously given enterally.
IAP was measured via the bladder, with patients in the supine position, using the closed loop system repeated measurements technique [17 (link)]. The IAP was measured at least twice a day when normal values were recorded, and at least four times a day if IAP was found to be elevated above 12 mmHg. Mean and maximum values of IAP were documented daily. Mean IAP was used to calculate daily GIF score. IAH was defined as an IAP that was persistently 12 mmHg or greater [18 (link)]. Abdominal compartment syndrome was defined as an IAP that was persistently above 20 mmHg, along with onset of a new organ failure. Gastrointestinal failure was considered to be present when IAH and FI occurred simultaneously.
ICU, 28-day and 90-day mortality, and durations of ICU stay and mechanical ventilation were primary outcome parameters. The SOFA+GIF score was calculated each day by summarizing the SOFA score and the GIF score of the respective day in each patient.
The Ethics Committee of the University of Tartu approved the study. Written informed consent was not considered necessary for the study, because it was observational in nature. No special interventions were applied. All of the data were rendered anonymous before analysis, and no harm resulted from the study that could be weighed against benefit.

Reintam A., Parm P., Kitus R., Starkopf J, & Kern H. (2008). Gastrointestinal Failure score in critically ill patients: a prospective observational study. Critical Care, 12(4), R90.

Publication 2008

Abdomen Abdominal Compartment Syndrome Abdominal Pain Diabetes Mellitus Diarrhea Ethics Committees Food Intolerance Ileus Index, Body Mass Inhalation Inotropism Lactates Laparotomy Mechanical Ventilation Operative Surgical Procedures Patients Positive End-Expiratory Pressure Pressure Sedatives Stomach Urinary Bladder Vasoconstrictor Agents Venous Pressure, Central Volume, Residual

Framingham Heart Failure Diagnostic Criteria

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2008

Ankle Cardiac Events Congestive Heart Failure Cough Dyspnea Edema Heart Sounds Paroxysmal Nocturnal Dyspnea Physicians Pleural Effusion Pulmonary Edema Rate, Heart Varices Venous Pressure, Central X-Rays, Diagnostic

Most recents protocols related to «Venous Pressure, Central»

Perioperative Anesthesia Management for Cardiac Surgery

Patients were premedicated with 1–2 mg lorazepam orally 1 h before surgery and received 0.1 mg kg⁻¹ morphine intramuscularly before entering the operating room where midazolam was given (0.01–0.05 mg kg⁻¹ intravenously) as needed for patient comfort. Usual monitoring was installed, including a 5-lead electrocardiogram, pulse oximeter, peripheral venous line, radial arterial line, 3-lm catheter, and fast-response thermodilution pulmonary artery catheter. Anesthesia was induced with 1 μg kg⁻¹ sufentanil and 0.04 mg kg⁻¹ midazolam, and muscle relaxation achieved with 0.1 mg kg⁻¹ pancuronium. After tracheal intubation, anesthesia was maintained with 1 μg kg⁻¹ h⁻¹ sufentanil and 0.04 mg kg⁻¹ h⁻¹ midazolam. Intravenous fluids (0.9% normal saline) were administered (7 cc kg⁻¹ h⁻¹) during surgery and titrated according to blood pressure and central venous pressure. A transesophageal echocardiography (TEE) omniplane probe was inserted. Institution of CPB was performed using ascending aortic cannulation and bi-caval or double stage cannulation of the right atrium. Intermittent (4:1) blood cardioplegia was administered during CPB; induction and temperatures ranged from 15 to 29 °C. For coronary revascularizations, systemic temperature was allowed to drift to 34 °C, valvular surgeries and complex procedures to 32–34 °C. Weaning from CPB was undertaken after rewarming to a systemic temperature > 36 °C.

Nguyen A.Q., Denault A.Y., Théoret Y, & Varin F. (2023). Inhaled milrinone in cardiac surgical patients: pharmacokinetic and pharmacodynamic exploration. Scientific Reports, 13, 3557.

Publication 2023

Anesthesia Arterial Lines Ascending Aorta Atrium, Right BLOOD Blood Pressure Cannulation Catheters Echocardiography, Transesophageal Electrocardiography Heart Heart Arrest, Induced Intubation, Intratracheal Lorazepam Midazolam Morphine Normal Saline Operative Surgical Procedures Pancuronium Patients Pulmonary Artery Pulse Rate Relaxations, Muscle Sufentanil Thermodilution Veins Venae Cavae Venous Pressure, Central

Standardized Liver Resection Techniques

All LLRs and OLRs were performed by the same team led by Dr. Chen and Dr. Zhang with the experience of more than 100 successful LLRs and 1000 successful OLRs at the time of 2013. A standard operation procedure was utilized in both LLR and OLR.
In OLR, the patient was placed in the supine position and monitored under general anesthesia. A right subcostal incision or midline incision was adopted depending on the tumor location, and after separating ligaments around the liver, intraoperative ultrasonography was used to identify tumor boundaries and potential satellite nodules or vascular invasion. The liver parenchyma was cut using a harmonic scalpel collaborating with controlled low central venous pressure. Total hepatic inflow control was performed through the intermittent Pringle maneuver to reduce blood loss during transection. The cut surface of the liver and abdominal cavity was washed with a large amount of sterile water after careful hemostasis, and an abdominal drain was deployed when total blood loss was more than 200 ml or bile leakage was suspected.
In LLR, the patient lied in the Reverse Trendelenburg position and was raised by a pillow under the right side of the back when the tumor was located in the right lobe of the liver. One 12-mm trocar was placed through the periumbilical abdomen as the thoroughfare for laparoscopy and carbon dioxide to maintain the pneumoperitoneum. Additional two to four 5-mm or 12-mm trocars were placed as needed. The primary surgeon stood on the right side of the patient, and two assistants stood on the left side. Intraoperative ultrasonography was routinely used to guide the resection planes. Parenchymal transection was similar to OLR, except that vessels were ligated mainly by Hem-o-lock clips rather than sutures. The specimen was placed into a specimen bag and extracted out of the abdomen through a midline incision started from the periumbilical port side. A drainage tube was placed under the same circumstances as the OLR.

Fu Y., Yang Z., Hu Z., Yang Z., Chen J., Wang J., Zhou Z., Xu L., Chen M, & Zhang Y. (2023). An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer. BMC Cancer, 23, 193.

Publication 2023

Abdomen Abdominal Cavity Bile Blood Vessel Carbon dioxide Clip Drainage General Anesthesia Hemostasis Laparoscopy Ligaments Liver Neoplasms Neoplasms by Site Patients Pneumoperitoneum Sterility, Reproductive Surgeons Sutures Trocar Ultrasonography Venous Pressure, Central

Perioperative Assessment of Right Ventricular Function

We collected the following baseline parameters: age, sex, height, weight and comorbidities. Preoperative use of cardiovascular medication, divided in ACEi, ARB, beta-blockers, CCB and diuretics, was registered. Collected perioperative parameters were type of surgery, preoperative haemodynamic variables (pulmonary artery pressure (PAP), central venous pressure (CVP), RV end-diastolic volume index (EDVi), CI, RVEF, SvO₂, intraoperative characteristics (cross clamp and cardiopulmonary bypass time, pericard closure, type of cardioplegia, perioperative fluid balance (FB)), CVP peak pressure at end of extracorporeal circulation, presence of stenosis in right coronary artery (RCA), revascularisation of RCA, haemodynamic parameters in first 10 min at ICU (PAP, CVP, EDVi, CI, RVEF, SvO₂). The perioperative echo assessment of LV and RV function, performed by the attending cardiac anesthesiologist, is reported to the ICU as good, moderate or poor. These data were collected as well. We chose to use the detailed near-continuous PAC measurements for the assessment of perioperative RV function. These measurements corresponded with the global echocardiographic assessment of the cardiac anaesthesiologist in a previous study.12 (link)

Bethlehem C., Bootsma I.T., De Lange F, & Boerma E.C. (2023). Identifying risk factors for perioperative decline in right ventricular performance in cardiac surgery patients: a prospective observational study in a tertiary care hospital. BMJ Open, 13(2), e068598.

Publication 2023

Adrenergic beta-Antagonists Anesthesiologist Artery, Coronary Cardiopulmonary Bypass Cardiovascular Agents Diastole Diuretics Echocardiography ECHO protocol Fluid Balance Heart Heart Arrest, Induced Hemodynamics Operative Surgical Procedures Pressure Pulmonary Artery Stenosis Venous Pressure, Central

Laparoscopic Liver Resection Procedure

For the LMH group, the patient will be placed in a left semi-decubitus position. Pneumoperitoneum will be created by carbon dioxide insufflation and the intra-abdominal pressure maintained at 13–15 mmHg. In addition to the camera port (10 mm), two 12-mm and two 5-mm ports will be used and adjusted according to tumour location and extent of resection. Laparoscopic ultrasonography will be used to confirm tumour location and guide liver transection. The extent of resection will depend on tumour location. Cholecystectomy will be performed. The anterior approach for major hepatectomy will be routinely adopted^{20 (link)}. Following liver hilum dissection to divide the appropriate hepatic artery and portal vein, liver transection will be performed using a combination of ultrasonic dissecting shears (Harmonic scalpel^®, BBT Medical, Wuhan, China), a vessel sealing system (Ligasure^®, Medtronic, Minneapolis, MN, USA), radiofrequency energy (TissueLink^®, Nissha Medical Technologies, Buffalo, NY, USA), and a laparoscopic-adopted Cavitron Ultrasonic Surgical Aspirator (CUSA^®, Soma Tech, Bloomfield, CT, USA) as determined by the operating surgeon. For vessels greater than 5 mm in diameter, Hem-o-lock or titanium clips will be used. An intermittent Pringle manoeuvre (20 min with 5 min rest for one cycle) will be selectively applied depending on intraoperative haemostasis. The central venous pressure will be routinely kept below 5 mmHg. The hepatic vein and portal pedicles will be transacted by laparoscopic linear stapler. The specimen will be retrieved through a protected wound using Pfannenstiel incision at the suprapubic region. An abdominal drain will be selectively placed on the liver transection surface according to the operating surgeon.

Ng K.K., Chong C.C., Lee K.F., Lai P.B., Cheng T.K., Chen H.W., Yi B, & Huang J.W. (2023). Asia-Pacific multicentre randomized trial of laparoscopic versus open major hepatectomy for hepatocellular carcinoma (AP-LAPO trial). BJS Open, 7(1), zrac166.

Publication 2023

Abdomen Abdominal Cavity Blood Vessel Buffaloes Carbon dioxide Carisoprodol Cholecystectomy Clip Dissection Hemostasis Hepatectomy Hepatic Artery Hepatic Vein Insufflation Laparoscopy Liver Neoplasms by Site Patients Pneumoperitoneum Pressure Surgeons Surgical Procedures, Laparoscopic Titanium Ultrasonics Ultrasonic Surgical Procedures Ultrasonography Veins, Portal Venous Pressure, Central Wounds

Invasive Hemodynamic Monitoring in Anesthetized Dogs

The anesthetized dogs were positioned in right-lateral recumbency. A 4-Fr saline-filled catheter was inserted into the left carotid artery to measure systemic arterial pressure (SAP) using a transducer (Edwards Lifesciences, Irvine, CA, USA) and a biological information monitor (BP-608 Evolution, Omron Healthcare, Kyoto, Japan). A saline-filled Swan–Ganz catheter (5-Fr thermodilution catheter 132F5, Edwards Lifesciences) was inserted through the left jugular vein and advanced into the main PA. The Swan–Ganz catheter was connected to a PowerLab system (AD Instruments), and PAP, central venous pressure (CVP), PAWP, and cardiac output (CO) were measured. The CO was calculated using a thermodilution method based on previous reports [19 (link),20 (link)]. The average of the three measurements is presented as the result.
The PVR and systemic vascular resistance (SVR) indices were calculated using the following formulas [21 (link),22 (link)]:

Body surface area (BSA; m^{2}) = \frac{10.1 \times body weight {(g)}^{\frac{2}{3}}}{10^{4}}

PVR index (dynes \cdot s \cdot {cm}^{- 5} \cdot m^{2}) = \frac{(mean PAP - mean PAWP)}{CO} \times 80 \times BSA

SVR index (dynes \cdot s \cdot {cm}^{- 5} \cdot m^{2}) = \frac{(mean SAP - mean CVP)}{CO} \times 80 \times BSA

Kameshima S., Nakamura Y., Uehara K., Kodama T., Yamawaki H., Nishi K., Okano S., Niijima R., Kimura Y, & Itoh N. (2023). Effects of a Soluble Guanylate Cyclase Stimulator Riociguat on Contractility of Isolated Pulmonary Artery and Hemodynamics of U46619-Induced Pulmonary Hypertension in Dogs. Veterinary Sciences, 10(2), 159.

Publication 2023

Biological Evolution Biopharmaceuticals Body Surface Area Body Weight Canis familiaris Cardiac Output Catheters Common Carotid Artery Diet, Formula Jugular Vein Pulmonary Wedge Pressure Saline Solution Thermodilution Total Peripheral Resistance Transducers Veins Venous Pressure, Central

Top products related to «Venous Pressure, Central»

Pulmonary artery catheter by Edwards Lifesciences

Sourced in United States

The Pulmonary Artery Catheter is a medical device designed to measure various hemodynamic parameters, including cardiac output, central venous pressure, and pulmonary artery pressure. It is commonly used in critical care and surgical settings to monitor and manage the patient's cardiovascular function.

Vivid 7 by GE Healthcare

Sourced in United States, Norway, United Kingdom, Japan, France, Canada, Germany, Belgium

The Vivid 7 is a high-performance ultrasound system designed for cardiovascular and general imaging applications. It features advanced imaging technologies and versatile capabilities to support comprehensive diagnostic assessments.

Powerlab by ADInstruments

Sourced in Australia, United States, United Kingdom, New Zealand, Germany, Japan, Spain, Italy, China

PowerLab is a data acquisition system designed for recording and analyzing physiological signals. It provides a platform for connecting various sensors and transducers to a computer, allowing researchers and clinicians to capture and analyze biological data.

Acuson sequoia by Siemens

Sourced in United States, Germany, China, United Kingdom

The Acuson Sequoia is a diagnostic ultrasound system designed for a variety of clinical applications. It features advanced imaging technologies to provide high-quality images for medical professionals. The Acuson Sequoia is a versatile system that can be used in different healthcare settings.

Spr 838 nr by Millar

The SPR-838 NR is a surface plasmon resonance (SPR) instrument designed for real-time, label-free analysis of biomolecular interactions. It measures changes in the refractive index near a sensor surface to detect and quantify binding events between molecules.

Bp791it 10 series plus automatic blood pressure monitor by Omron

Sourced in United States

The Omron BP791IT 10 series Plus Automatic Blood Pressure Monitor is a device designed to measure and display blood pressure and pulse rate. It features automatic inflation and deflation of the arm cuff, and can store up to 100 readings with date and time stamps.

Swan ganz catheter by Edwards Lifesciences

Sourced in United States

The Swan-Ganz catheter is a medical device used to measure various hemodynamic parameters, such as cardiac output, pulmonary artery pressure, and central venous pressure. It is a long, thin, flexible tube that is inserted into a vein and advanced into the pulmonary artery, allowing for the monitoring of cardiovascular function.

Cobas b221 by Roche

Sourced in Germany, Switzerland, United Kingdom, United States

The Cobas b221 is a fully automated blood gas and electrolyte analyzer designed for use in hospitals and clinical laboratories. It measures key parameters such as pH, blood gases, electrolytes, and metabolites from whole blood samples. The Cobas b221 is a compact and user-friendly device that provides accurate and reliable results to support clinical decision-making.

Vivid e7 by GE Healthcare

Sourced in United States, Norway

The Vivid E7 is a versatile ultrasound system designed for a wide range of clinical applications. It features high-quality imaging capabilities and a compact, ergonomic design.

Intellivue mp50 by Philips

Sourced in Germany, United States, Netherlands

The IntelliVue MP50 is a patient monitor that provides comprehensive physiological data monitoring. It is designed to measure and display a variety of patient vital signs, such as heart rate, blood pressure, and oxygen saturation. The monitor is intended for use in healthcare settings, such as hospitals and clinics, to support patient care and monitoring.

What are the main factors that influence central venous pressure?

Central venous pressure is influenced by a variety of factors, including blood volume, venous tone, and the activity of the heart. Blood volume and changes in venous tone can impact the pressure within the major veins carrying blood back to the heart. Additionally, the pumping action of the heart, which drives blood flow, is a key determinant of central venous pressure. Understanding these underlying factors is important for interpreting central venous pressure measurements and their implications for cardiovascular function.

How can monitoring central venous pressure provide insights into a patient's hemodynamic status?

Monitoring central venous pressure can give clinicians valuable insights into a patient's hemodynamic status, which refers to the dynamics of blood flow and pressure within the cardiovascular system. Changes in central venous pressure can indicate alterations in blood volume, cardiac function, or vascular resistance, which can have important implications for a patient's overall health and guide clinical decision-making. By closely tracking central venous pressure, healthcare providers can make more informed assessments and adjust treatments accordingly.

What are some common applications of central venous pressure monitoring?

Central venous pressure monitoring has a variety of clinical applications, including assessing fluid status, evaluating cardiac function, and guiding fluid resuscitation in critically ill patients. It is particularly useful in managing patients with conditions like heart failure, sepsis, or acute kidney injury, where changes in central venous pressure can provide insights into hemodynamic stability and guide appropriate therapeutic interventions. Additionally, central venous pressure monitoring is an important tool in anesthesia and critical care settings to optimize patient management during surgical procedures and in the intensive care unit.

How can PubCompare.ai assist in the optimal use and comparison of Venous Pressure, Central protocols?

PubCompare.ai's AI-driven platform can be invaluable in optimizing the use and comparison of protocols related to Venous Pressure, Central. The platform allows researchers to efficiently screen the literature and identify the most effective protocols for their specific research goals. By leveraging AI-powered analysis, PubCompare.ai can highlight key differences in protocol effectiveness, enabeling researchers to choose the best approach for reproducibility and accuracy. This can save time, reduce redundant efforts, and ultimately accelerate research progress in the field of Venous Pressure, Central.

Are there different types or variations of central venous pressure measurements?

Yes, there are different types and variations of central venous pressure measurements. The most common method is direct measurement, where a catheter is inserted into a central vein, typically the internal jugular, subclavian, or femoral vein, to directly assess the pressure. However, there are also indirect methods, such as using a peripheral intravenous line or estimating central venous pressure from physical examination findings. The specific approach used may vary depending on the clinical setting, patient characteristics, and the healthcare provider's preference and expertise. Understanding these different measurement techniques is important for interpreting central venous pressure values and their clinical significance.

More about "Venous Pressure, Central"

Central venous pressure (CVP) refers to the pressure within the major veins that carry deoxygenated blood from the upper and lower body back to the heart.
This pressure is an important indicator of cardiovascular function and is influenced by factors such as blood volume, venous tone, and the activity of the heart.
Monitoring CVP can provide valuable insights into a patient's hemodynamic status and guide clinical decision-making.
Researchers and clinicians can leverage AI-driven platforms like PubCompare.ai to easily locate and compare research protocols related to CVP, identifying the best approach for their needs and accelerating their work.
Key subtopics around CVP include pulmonary artery catheterization, which is often used to measure CVP directly, as well as various devices and technologies like the Vivid 7 and PowerLab systems, Acuson Sequoia ultrasound, SPR-838 NR pressure sensors, BP791IT 10 series Plus Automatic Blood Pressure Monitors, Swan-Ganz catheters, Cobas b221 blood gas analyzers, Vivid E7 echocardiography, and IntelliVue MP50 patient monitors, which can be used to indirectly assess CVP.
By exploring these related terms and technologies, researchers can gain a deeper understanding of the factors that influence central venous pressure and how it can be measured and monitored.
This knowledge can help optimize research protocols and improve patient care.